inveox

Founded in 2017, inveox  GmbH develops systems to digitize, automate and connect pathology laboratories. With an innovative automation system for sample preparation in histopathology, inveox increases efficiency and safety in pathology laboratories. As a result, the risk of operational irregularities and potential misdiagnoses are significantly reduced and the patient safety – especially in cancer diagnostics – is greatly improved. Since it's foundation, inveox has won a variety of awards including the 2017 "Startup des Jahres," Top 50 Start-ups 2017 from Für Gründer, the "Golden Pretzel" at Bits & Pretzels 2018 and the 2019 EIT Health Award. It was also listed on the 2018 Forbes list of “most promising startups,” participated in the Roche Diagnostics/ Plug&Play Digital Health Accelerator 2018 and has been a member of the World Economic Forum since 2019. inveox was featured on LinkedIn's Top Startups of 2019: https://bit.ly/3eBDLwK Check out inveox co-found and CEO, Dominik Sievert, in this video from Munich Startup: https://bit.ly/2SeqCSV

Witryna

https://inveox.com

Link zewnętrzny organizacji inveox

Branża

Produkcja sprzętu medycznego

Wielkość firmy

51-200 pracowników

Siedziba główna

Garching bei München, Bayern

Rodzaj

Spółka prywatna

Data założenia

2017

Specjalizacje

Pathology 4.0, Lab IoT, Lab Automation, MedTech, Histopathology, Digital Health i Digitalization